Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Liabilities and Shareholders Equity (2020 - 2025)

Cellebrite DI has reported Liabilities and Shareholders Equity over the past 6 years, most recently at $938.9 million for Q4 2025.

  • Quarterly results put Liabilities and Shareholders Equity at $938.9 million for Q4 2025, up 35.95% from a year ago — trailing twelve months through Dec 2025 was $2.6 billion (up 30.46% YoY), and the annual figure for FY2025 was $938.9 million, up 35.95%.
  • Liabilities and Shareholders Equity for Q4 2025 was $938.9 million at Cellebrite DI, up from $690.6 million in the prior quarter.
  • Over the last five years, Liabilities and Shareholders Equity for CLBT hit a ceiling of $938.9 million in Q4 2025 and a floor of $339.8 million in Q4 2021.
  • Median Liabilities and Shareholders Equity over the past 5 years was $532.9 million (2023), compared with a mean of $581.1 million.
  • Biggest five-year swings in Liabilities and Shareholders Equity: fell 6.75% in 2021 and later surged 35.95% in 2025.
  • Cellebrite DI's Liabilities and Shareholders Equity stood at $339.8 million in 2021, then grew by 18.69% to $403.3 million in 2022, then skyrocketed by 32.13% to $532.9 million in 2023, then grew by 29.59% to $690.6 million in 2024, then surged by 35.95% to $938.9 million in 2025.
  • The last three reported values for Liabilities and Shareholders Equity were $938.9 million (Q4 2025), $690.6 million (Q4 2024), and $532.9 million (Q4 2023) per Business Quant data.